Immunodominant allergens as molecular targets for allergen immunotherapy
While there has been tremendous progress in allergen molecular biology, knowledge of the epitopes recognized by IgE antibodies is in its infancy. The production of IgE monoclonal antibodies from symptomatic allergic patients has enabled structures of allergen/IgE complexes to be solved and has defined immunodominant epitopes on indoor allergens and foods. High resolution structures of IgE epitopes on Der p 2, Can f 1, Fel d 7, Fel d 1, Ara h 2, Ara h 6 and Bet v 1 have been determined. Mutations of these epitopes show reduced IgE binding in vitro and confer protection in a murine model of anaphylaxis, making them candidate hypoallergens for potential therapeutic use. Allergens and IgE antibodies are important tools for next generation diagnostics using basophil or mast cell activation tests. Immunodominant allergens from diverse sources are molecular targets for novel therapeutics using virus-like particle vaccines or plant-based enveloped particles. Allergen-specific precision biologics are being engineered to target immunodominant allergens using high affinity IgG antibodies to block IgE epitopes and to downregulate signal transduction through IgE pathways. Promising data from clinical trials suggests that targeting one or more immunodominant allergens provides symptomatic relief from challenge with allergen extracts. Innovative strategies targeting, in effect, the active pharmaceutical ingredients of conventional allergen extracts are poised to develop new therapeutic options for treatment of patients with allergic diseases.
Authors
- Martin D. Chapman (ORCID: https://orcid.org/0000-0002-0845-3632)
- Scott Alan Smith (ORCID: https://orcid.org/0000-0002-5519-8662)
- M. Chruszcz (ORCID: https://orcid.org/0000-0001-7521-5485)
- Anna Pomés (ORCID: https://orcid.org/0000-0002-8729-1829)
- Kriti Khatri (ORCID: https://orcid.org/0000-0002-4757-2677)
- Ben W. Spiller
Institutions
- Vanderbilt University (US)
- University of Virginia (US)
- Michigan State University (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-13
- DOI
- https://doi.org/10.3389/fimmu.2026.2012996
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases